Literature DB >> 18465084

A novel technique for isolating functional mast cells from the heart.

L G Morgan1, S P Levick, T G Voloshenyuk, D B Murray, M F Forman, G L Brower, J S Janicki.   

Abstract

OBJECTIVE AND
DESIGN: The purpose of this study was to determine the feasibility of adapting peritoneal and pleural mast cell isolation techniques to recover cardiac mast cells that retain their functional response to the secretagogue, compound 48/80.
METHODS: Using a novel protocol in rats, viable epicardial mast cells were recovered by aspiration of HBSS injected into the pericardial space. Functionality of these cells was determined by ELISA quantification of histamine release in response to compound 48/80, calcium ionophore A23187 and substance P. Mast cell phenotype was determined based on the presence of chymase and tryptase demonstrated by immunofluorescence, alcian blue-safranin staining, and Western blotting.
RESULTS: Mast cells isolated in this manner have low basal rates of histamine release and are highly responsive to these secretagogues. These epicardial mast cells were of the connective tissue type, which is consistent with previous reports characterizing cardiac mast cells isolated from the heart by enzymatic dispersion techniques.
CONCLUSIONS: This novel pericardial aspiration technique facilitates the straightforward characterization of isolated epicardial mast cell functionality in a controlled in vitro environment, furthering our understanding of their contribution to myocardial disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465084     DOI: 10.1007/s00011-007-7059-5

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  11 in total

Review 1.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

Review 2.  Potential targets for intervention in radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Scott P Levick
Journal:  Methods Mol Biol       Date:  2015

4.  Isolation of functional cardiac immune cells.

Authors:  Jennifer L McLarty; Giselle C Meléndez; William J Spencer; Scott P Levick; Gregory L Brower; Joseph S Janicki
Journal:  J Vis Exp       Date:  2011-12-05       Impact factor: 1.355

5.  Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

Authors:  Giselle C Meléndez; Jianping Li; Brittany A Law; Joseph S Janicki; Scott C Supowit; Scott P Levick
Journal:  Cardiovasc Res       Date:  2011-09-09       Impact factor: 10.787

6.  Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha.

Authors:  David B Murray; Scott P Levick; Gregory L Brower; Joseph S Janicki
Journal:  J Mol Cell Cardiol       Date:  2010-04-18       Impact factor: 5.000

7.  Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart.

Authors:  Scott P Levick; David B Murray; Joseph S Janicki; Gregory L Brower
Journal:  Hypertension       Date:  2010-01-04       Impact factor: 10.190

8.  Substance P-mediated cardiac mast cell activation: An in vitro study.

Authors:  Scott P Levick; Gregory L Brower; Joseph S Janicki
Journal:  Neuropeptides       Date:  2019-01-08       Impact factor: 3.286

9.  Preclinical research into basic mechanisms of radiation-induced heart disease.

Authors:  M Boerma; M Hauer-Jensen
Journal:  Cardiol Res Pract       Date:  2010-10-04       Impact factor: 1.866

10.  Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart.

Authors:  Alexander Widiapradja; Edward J Manteufel; Heather M Dehlin; James Pena; Paul H Goldspink; Amit Sharma; Lauren L Kolb; John D Imig; Joseph S Janicki; Bao Lu; Scott P Levick
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.